Search Results - "Asirvatham, Susan"

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys) by Okikiolu, Jumoke, Woodley, Claire, Cadman-Davies, Llywelyn, O'Sullivan, Jennifer, Radia, Deepti, Garcia, Natalia Curto, Harrington, Patrick, Kordasti, Shahram, Asirvatham, Susan, Sriskandarajah, Priya, Saunders, Jamie, Saha, Chandan, Sanchez, Irene, deLavallade, Hugues, McLornan, Donal P, Harrison, Claire N

“…Despite widespread use of Pegylated forms of Inteferon in the management of Myeloproliferative Neoplasms (MPN), most clinicians have experience predominantly…”
Get full text

Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms by Duminuco, Andrea, Au Yeung, Joshua, Vaghela, Raj, Virdee, Sukhraj, Woodley, Claire, Asirvatham, Susan, Curto‐Garcia, Natalia, Sriskandarajah, Priya, O'Sullivan, Jennifer, Lavallade, Hugues, Radia, Deepti, Kordasti, Shahram, Palumbo, Giuseppe, Harrison, Claire, Harrington, Patrick

Get full text

Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib by Harrington, Patrick, Doores, Katie J., Saunders, Jamie, de Lord, Marc, Saha, Chandan, Lechmere, Thomas, Khan, Hataf, Lam, Ho Pui Jeff, Reilly, Amy O’, Woodley, Claire, Asirvatham, Susan, Dillon, Richard, Curto-Garcia, Natalia, Sullivan, Jennifer O’, Kordasti, Shahram, Raj, Kavita, Malim, Michael H., Radia, Deepti, McLornan, Donal, Harrison, Claire, de Lavallade, Hugues

Get full text

Low‐dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center by Khan, Alesia, Woodley, Claire, Radia, Deepti, Mikhaeel, George N., Brady, Jessica, Garcia, Natalia Curto, Harrington, Patrick, O'Sullivan, Jennifer, Kordasti, Shahram, Francis, Yvonne, Asirvatham, Susan, Ali, Sahra, Sriskandarajah, Priya, Saunders, Jamie, Lavallade, Hugues, McLornan, Donal P., Harrison, Claire N.

Get full text

Large Scale Internet‐based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS‐CoV‐2 (COVID‐19) Vaccination Strategies in 2021 by Saunders, Jamie, Curto‐Garcia, Natalia, Sriskandarajah, Priya, O'Sullivan, Jennifer, Woodley, Claire, Asirvatham, Susan, Campbell‐Drew, Marion, Mathias, Jonathan, Ellis, Tim, Baker, Nona, Radia, Deepti H., Ali, Sahra, Kordasti, Shahram, Harrington, Patrick, Lavallade, Hugues, McLornan, Donal P., Harrison, Claire N.

“…Supplemental Digital Content is available in the text…”
Get full text

A Snapshot Audit of Symptom Burden in Patients with Indolent Systemic Mastocytosis Utilising the ISM-SAF © within a UK Centre of Excellence: Guy's and St Thomas' NHS Foundation Trust by Veitch, Scott, Asirvatham, Susan, Sriskandarajah, Priya, Saha, Chandan, Oni, Clare, Grattan, Clive, Radia, Deepti H.

“…Background: Indolent systemic mastocytosis (ISM) is a rare, clonal haematological neoplasm driven by the KIT D816V mutation in up to 95% of cases. It is…”
Get full text

Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype by Harrington, Patrick, Dillon, Richard, Radia, Deepti, McLornan, Donal, Woodley, Claire, Asirvatham, Susan, Raj, Kavita, Curto‐Garcia, Natalia, Saunders, Jamie, Kordasti, Shahram, Harrison, Claire, Lavallade, Hugues

“…Summary The search for novel targets in chronic myeloid leukaemia (CML) is ongoing, to improve treatment efficacy in refractory disease and increase…”
Get full text

Immune Checkpoint Analysis of T Effectors and Regulatory T Cells in Patients with CML Reveals Increased Expression at Diagnosis and with Refractory Disease by Harrington, Patrick, Dillon, Richard, Radia, Deepti H., McLornan, Donal P., Woodley, Claire, Asirvatham, Susan, Raj, Kavita, Curto-Garcia, Natalia, Kordasti, Shahram, Harrison, Claire N., de Lavallade, Hugues

“…Introduction: The search for potential new targets to improve outcomes in patients with CML is ongoing, with a view to improve treatment efficacy for those…”
Get full text

Enhanced Cardiovascular Risk Assessment Incorporating Natural Language Processing and Qrisk-3 Score Determination in Patients with Essential Thrombocythaemia by Harrington, Patrick, Duminuco, Andrea, Au Yeung, Joshua, Singh Virdee, Sukhraj, Vaghela, Raj, Asirvatham, Susan, Bone, Rosemarie, Woodley, Claire, Thaw, Kyaw Htin, Cadman-Davies, Llywelyn, O'Sullivan, Jennifer, Sriskandarajah, Priya, Curto-Garcia, Natalia, Kordasti, Shahram, de Lavallade, Hugues, Radia, Deepti H., Teo, James, Harrison, Claire N

“…Introduction: Fundamental to management of patients with essential thrombocythaemia (ET) is assessment, and reduction of thrombotic risk. We present a machine…”
Get full text

‘Application of Prognostic Scoring in Systemic Mastocytosis Patients within a UK Centre of Excellence: Guys and St Thomas’ NHS Foundation Trust. by Sriskandarajah, Priya, Oni, Clare, Woodley, Claire, Asirvatham, Susan, Ciesielska, Monika, Asinobi, Chienye, Todd, Rebecca, Curto-Garcia, Natalia, O'Sullivan, Jennifer, Saha, Chandan, Olaoni, Thompson, Green, Anna, Miki, Yurina, Ong, Mark, McLornan, Donal P, Harrison, Claire N., Grattan, Clive, Radia, Deepti H.

“…▪ Background: Systemic mastocytosis (SM) is a disorder of neoplastic mast cells ranging from indolent to aggressive multi-system disease. We previously…”
Get full text

MPN-654 Analysis of Cardiovascular Risk in 920 Patients With Myeloproliferative Neoplasms Using Natural Language Processing by Duminuco, Andrea, Au Yeung, Joshua, Virdee, Sukhraj, Vaghela, Raj, Woodley, Claire, Asirvatham, Susan, Curto-Garcia, Natalia, Sriskandarajah, Priya, O'sullivan, Jennifer, Radia, Deepti, De Lavallade, Hugues, Kordasti, Shahram, Palumbo, Giuseppe, Harrison, Claire, Harrington, Patrick

“…Thromboembolic events represent the most common cause of morbidity and mortality in myeloproliferative neoplasms (MPN). Natural language processing is a branch…”
Get full text

Analysis of Cardiovascular Risk in 920 Patients With Myeloproliferative Neoplasms Using Natural Language Processing by Duminuco, Andrea, Au Yeung, Joshua, Virdee, Sukhraj, Vaghela, Raj, Woodley, Claire, Asirvatham, Susan, Curto- Garcia, Natalia, Sriskandarajah, Priya, O'sullivan, Jennifer, Radia, Deepti, De Lavallade, Hugues, Kordasti, Shahram, Palumbo, Giuseppe, Harrison, Claire, Harrington, Patrick

Get full text

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders by Harrington, Patrick, Kurshan, Ashwini, Delord, Marc, Lechmere, Thomas, Sheikh, Amna, Saunders, Jamie, Saha, Chandan, Dillon, Richard, Woodley, Claire, Asirvatham, Susan, Curto-Garcia, Natalia, Sullivan, Jennifer O’, Kordasti, Shahram, Radia, Deepti, McLornan, Donal, Malim, Michael H., Harrison, Claire, Doores, Katie J., de Lavallade, Hugues

Get full text

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys) by Okikiolu, Jumoke, Woodley, Claire, Cadman-Davies, Llywelyn, O'Sullivan, Jennifer, Radia, Deepti, Garcia, Natalia Curto, Harrington, Patrick, Kordasti, Shahram, Asirvatham, Susan, Sriskandarajah, Priya, Saunders, Jamie, Saha, Chandan, Sanchez, Irene, deLavallade, Hugues, McLornan, Donal P, Harrison, Claire N

Get full text

Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center by Khan, Alesia, Woodley, Claire, Radia, Deepti, Mikhaeel, George N, Brady, Jessica, Garcia, Natalia Curto, Harrington, Patrick, O'Sullivan, Jennifer, Kordasti, Shahram, Francis, Yvonne, Asirvatham, Susan, Ali, Sahra, Sriskandarajah, Priya, Saunders, Jamie, de Lavallade, Hugues, McLornan, Donal P, Harrison, Claire N

Get full text